Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1237 |
---|---|
Product Name | Anti-Human CD200 Recombinant Antibody |
Molecular Name | Samalizumab |
Alias | Anti-CD200 Recombinant Antibody, Research Grade Samalizumab |
CAS Number | 1073059-33-2 |
Target | CD200[Homo sapiens] |
Isotype | IgG2-G4 Kappa |
Clonity | Monoclonal |
Host | Mouse |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, WB |
Buffer | PBS, pH7.5 |
Background | Samalizumab is a humanized monoclonal antibody designed for oncology indications. Samalizumab was developed by Alexion Pharmaceuticals. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |